IBM still holds a 13% stake and has two nonvoting board seats.

Article 16 Representatives shall be invited to attend the meeting of the SCMPC as nonvoting participants.

The panel is a nonvoting one, but even FDA advisory panels which don't vote are still reviewed by the agency.